Navigation Links
Cipher Appeals FDA's Decision On CIP-TRAMADOL ER
Date:12/4/2007

nto Stock Exchange under the symbol 'DND' and has approximately 24 million shares outstanding. For more information, please visit http://www.cipherpharma.com.

Forward-Looking Statements

Statements made in this news release, other than those concerning historical financial information, may be forward-looking and therefore subject to various risks and uncertainties. Some forward-looking statements may be identified by words like "may", "will", "anticipate", "estimate", "expect", "intend", or "continue" or the negative thereof or similar variations. Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. Factors that could cause results to vary include those identified in the Company's Annual Information Form and other filings with Canadian securities regulatory authorities, such as the applicability of patents and proprietary technology; possible patent litigation; regulatory approval of products in the Company's pipeline; changes in government regulation or regulatory approval processes; government and third-party payer reimbursement; dependence on strategic partnerships for product candidates and technologies, marketing and R&D services; meeting projected drug development timelines and goals; intensifying competition; rapid technological change in the pharmaceutical industry; anticipated future losses; the ability to access capital to fund R&D; and the ability to attract and retain key personnel. All forward-looking statements presented herein should be considered in conjunction with such filings. The Company does not undertake to update any forward-looking statements; such statements speak only as of the date made.


'/>"/>
SOURCE Cipher Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Cipher reports third quarter fiscal 2007 results
2. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
3. NBME Appeals Massachusetts Judges Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Gerresheimer to be Included in the SDAX Early Decision on Inclusion in the MDAX on September 5, 2007
6. Microarray provides 3 genomic guides to breast cancer treatment decisions
7. Spectranetics to Appeal Decision in Patent Litigation
8. Canadas government funds $1.6M in modern geography to support public health decisions
9. Parents participation in medical decisions linked to self-efficacy
10. Decision-making by residents on-call has miniscule negative impact on patient care
11. Political decisions harming cancer treatment in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... (PRWEB) July 31, 2014 Ticket Down ... at Levi’s Stadium in Santa Clara, California. Fans in the ... see some of the best club and national teams in the ... to Brazil, this has become the best time to be a ... and special events being held on American soil this year, as ...
(Date:7/31/2014)... 2014 David Kekich, anti-aging icon ... ) is thrilled that the acceptance of his ... Artificial Intelligence (AI) algorithms and then screening thousands ... acceptance. , “It took longer than ... proof is in," said Kekich. "Client acceptance is ...
(Date:7/31/2014)... July 31, 2014 Much of the liver,s metabolic ... body clock and UC Irvine researchers have now ... The study, published online today in Cell , ... metabolism and points the way to more focused drug ... obesity and diabetes. , Paolo Sassone-Corsi, UCI,s Donald Bren ...
(Date:7/31/2014)... July 31, 2014 BioProcess ... delivering cutting-edge information focused on the development ... launched its newly designed website, http://www.bioprocessintl.com ... by providing visitors specialized content under upstream ... business areas. As the site is updated ...
(Date:7/31/2014)... -- Many teens never outgrow their "growing pains," according ... for years, affecting teens, participation in sports and other ... growing pains can become chronic, the researchers cautioned. ... three young people between the ages of 12 and ... Michael Skovdal Rathleff, a physiotherapist from Aarhus University. "Seven ...
Breaking Medicine News(10 mins):Health News:Mexico vs. Chile Tickets Levi’s Stadium: Ticket Down Slashes Ticket Prices for Chile vs. Mexico at Levi’s Stadium in Santa Clara, California on September 6th 2Health News:Mexico vs. Chile Tickets Levi’s Stadium: Ticket Down Slashes Ticket Prices for Chile vs. Mexico at Levi’s Stadium in Santa Clara, California on September 6th 3Health News:MaxLife Solution™ Expands Distribution Globally for Breakthrough Anti-Inflammatory Support Supplement – InflaGene™ 2Health News:Strict genomic partitioning by biological clock separates key metabolic functions 2Health News:BioProcess International Launches New Website 2Health News:Teen 'Growing Pains' May Persist For Years 2
... University of Southern ... Angeles County Hospital, STEINBACH, Manitoba, Feb. 4 Partnered ... of Santa Monica, MCM,served as the millwork provider for the ... highly detailed work involving a large,number of custom nursing stations ...
... MCM,s Biggest Project Completed With Detailed Precision, ... a joint,venture of Pei Architects and Perkins & ... replacement hospital in Westwood, the Ronald,Reagan UCLA Medical ... Angeles,California. Featuring over 70,000 square feet of wall ...
... deficits , , MONDAY, Feb. 4 (HealthDay News) -- Eye ... during pregnancy but who don,t have the distinctive facial ... suggests. , "Eyeblink conditioning (EBC) is a Pavlovian ... such as a tone, with an unconditioned stimulus, such ...
... Renowned esthetician, Karen,Dunlap, has developed an advanced ... the number-one most nutritious and powerful food,in the ... between science and,nature, Dunlap discovered that topical application ... its benefits. Her new signature facial, the,Acai Berry ...
... Progen,Pharmaceuticals, Management Team (ASX: PGL; Nasdaq: PGLA) will ... 9.00am,Australian (Sydney time) and Monday 4 February at 5:00pm ... overview of the Cellgate, Inc.,acquisition and will be available ... refer to the relevant presentation at: http://www.progen-pharma.com , ...
... Trust for America,s,Health warns that the proposed 7 percent ... (CDC) in the president,s fiscal year 2009,budget could harm ... CDC would fall to a six year low for ... are skyrocketing, we should be,investing more to keep Americans ...
Cached Medicine News:Health News:MCM Completes LAC+USC Replacement Medical Facility Project 2Health News:Eye Blinks May ID Fetal Alcohol Exposure 2Health News:Breakthrough 'Acai Berry Anti-Aging Facial' Applies Benefits of Nature's Super-Food to the Skin 2Health News:Progen Investor Teleconference Dial In Details 2Health News:Cuts to HHS Could Leave Americans' Health in Critical Condition, TFAH Says; New Poll Shows Americans Believe Disease Prevention is Key to Reducing Healthcare Costs 2
(Date:7/31/2014)... LAWRENCEVILLE, N.J. , July 31, 2014  Celsion ... the Company will host a conference call to discuss ... EDT on Thursday, August 7, 2014. To participate in ... North America ) or 1-785-830-1924 (International/Toll) and ask ... (Conference Code: 8283269) to register ten minutes before the ...
(Date:7/31/2014)... , 31. Juli 2014 Marken ... Miami bekanntgegeben, um die wachsenden ... und Lateinamerika zu erfüllen. Die neu ausgebaute Einrichtung ... Proben und für die Zusammenlegung von Sendungen in ... zusätzliche Lagerkapazität bereitstellen.   Logo - ...
(Date:7/31/2014)... LAVAL, Quebec, July 31, 2014   , 2014 ... over the prior year , Overall organic growth was 4% ... facial injectable products; Bausch + Lomb grew 12% , ... increase of 43% , 2014 Second Quarter GAAP Operating ... , Highlights of the Second Quarter , Launched ...
Breaking Medicine Technology:Celsion Corporation to Hold Second Quarter 2014 Financial Results 2Marken erweitert regionales Logistikzentrum in Miami 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 26Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 27Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 28Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 29Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 30Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 31Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 32
... June 14, 2011 /PRNewswire-iReach/ -- URINOZINC® ... (Photo:   http://photos.prnewswire.com/prnh/20110614/CG20097 ) ... available at all corporate-owned GNC Live Well stores ... 1935, GNC has more than 6,000 stores spread ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ) ... filed an Abbreviated New Drug Application (ANDA) with ... approval to market Olopatadine Hydrochloride Ophthalmic Solution USP, ... is a generic version of Alcon, Inc.,s Pataday™ ...
Cached Medicine Technology:Patented URINOZINC® Prostate Formula Now Available at GNC Stores 2Patented URINOZINC® Prostate Formula Now Available at GNC Stores 3Watson Confirms Pataday™ Patent Challenge 2Watson Confirms Pataday™ Patent Challenge 3
... The iCycler thermal cycler maximizes what ... laboratory. It features multiple sample formats, an ... direct upgradability to real-time quantitative PCR. The ... of what a thermal cycler can do ...
... small footprint, simple intuitive programming and almost ... the ideal personal cycler in the modern ... and the self-adjusting heated lid allows a ... vessels or a microplate of 5 x ...
... The system includes: Mx3005P instrument ... choice of five (5) filters. The ... I (492nm-516nm), HEX/JOE/VIC (535nm-555nm), ROX/Texas Red ... Also included: desktop computer, Mx3005P analysis ...
... The SmartCycler System is a rapid, real-time ... prepared biological samples. By automating much of ... site individually programmable, it is the fastest, ... now on the market. The SmartCycler delivers ...
Medicine Products: